Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 Biomarker disease BEFREE This case highlights the need to include BCR/ABL1 fusion testing to accurately diagnose pediatric patients presenting with isolated thrombocytosis. 29187020 2019
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 GeneticVariation disease BEFREE In agreement with published data, our results showed association of the BCR-ABL1 transcript e14a2 with thrombocytosis and the BCR-ABL1 transcript e13a2 with higher leukocytosis in patients with chronic myeloid leukemia. 28437552 2017
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 GeneticVariation disease BEFREE This long-sought common mutation in BCR/ABL1-negative MPD raises many provocative biological and clinical questions, and demands re-evaluation of prevailing diagnostic algorithms for erythrocytosis and thrombocytosis. 16321848 2006
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 GeneticVariation disease BEFREE There is controversy over the proper classification of thrombocytosis associated with the pathological BCR-ABL gene rearrangement; such cases are not clearly distinguishable from chronic myelogenous leukemia (CML) and should be provisionally classified as CML. 12187022 2002
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 GeneticVariation disease BEFREE A novel BCR-ABL rearrangement in a Philadelphia chromosome-positive chronic myelogenous leukaemia variant with thrombocythaemia. 9519786 1998
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 GeneticVariation disease BEFREE The c3-a2 type of BCR/ABL junction seems to be associated with elevated platelet count and thus could form a novel clinical entity different from typical CML. 8759898 1996
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 GeneticVariation disease BEFREE Among 84 consecutive patients with chronic phase Ph-positive chronic myeloid leukemia (CML) who were investigated for the hybrid BCR/ABL mRNA, in six cases (7%) the disease mimicked essential thrombocythemia (ET) at presentation, because of marked thrombocytosis (platelet counts ranging from 1003 x 10(9)/l to 2800 x 10(9)/l) and moderate leukocytosis (WBC counts from 10 x 10(9)/l to 19 x 10(9)/l). 8684009 1996
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.170 Biomarker disease HPO